Professor Catriona Bradshaw is a clinician researcher and Head of Research Translation and Mentorship at Melbourne Sexual Health Centre, School of Translational Medicine, Monash University. She holds additional roles as Clinical Professor at the University of Melbourne and Principal Research Fellow at the Burnet Institute. Her work focuses on translational research to improve STI treatment, antimicrobial resistance strategies, and reproductive health interventions. Bradshaw leads the Centre to Impact Antimicrobial Resistance (Monash University) and co-directs the ARC Research Hub to combat Antimicrobial Resistance across multiple institutions. Education: PhD in Sexual Health Medicine from the University of Melbourne (2007), MBBS (Hons) in Medicine and Surgery. Fellowships include FAChSHM and FAHMS (Australian Academy of Health and Medical Sciences). Research Interests: Prioritizes Mycoplasma genitalium (STI superbug) and bacterial vaginosis research, developing diagnostics and resistance-guided therapies. Recent breakthroughs include male partner treatment trials for BV and surveillance systems for antimicrobial resistance. Her work has influenced global STI guidelines and policy. Awards: Recipient of the L'Oréal-UNESCO Women in Science Award (2009), Eureka Prize for Infectious Diseases (2022), and multiple team awards for innovation and research excellence. Active in media engagements and promoting gender equity in science. Grants & Projects: Leads NHMRC-funded studies on drug-resistant STIs and ARC Hub initiatives. Collaborates internationally on AMR surveillance and diagnostic development. Member of key committees like WHO AMR Expert Working Group and the International Society for STD Research. Labs/Teams: Directs The Genital Microbiota and Mycoplasma Group and co-heads the National Genital Microbiota Consortium. Active in Monash University's Infection and Immunity Network (UNITY).












